ALBERT DAVID
Back to Income Statement
|
ALBERT DAVID Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹346 Cr | ₹362 Cr | ₹342 Cr | ₹314 Cr | ₹247 Cr |
What is the latest Revenue of ALBERT DAVID ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹362 Cr |
| Mar2023 | ₹342 Cr |
| Mar2022 | ₹314 Cr |
| Mar2021 | ₹247 Cr |
How is Revenue of ALBERT DAVID Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹346 Cr | -4.61 | |
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | 26.70 | |
| Mar2021 | ₹247 Cr | - | |
Compare Revenue of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹387.5 Cr | 5.9% | -3.9% | -21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 5.9% |
-3.9% |
-21.4% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses